Outcomes According to MSKCC Risk Score with Focus on the Intermediate-Risk Group in Metastatic Renal Cell Carcinoma Patients Treated with First-Line Sunitinib: A Retrospective Analysis of 2390 Patients

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Fiala Ondřej; Fínek Jindřich; Poprach Alexandr; Melichar Bohuslav; Kopecký Jindřich; Zemanová Milada; Kopečková Kateřina; Mlcoch Tomas; Dolezal Tomas; Capkova Lenka; Büchler Tomáš

Journal title: Cancers

Journal number: 12/4

Journal publisher: Multidisciplinary Digital Publishing Institute (MDPI)

Published year: 2020

DOI identifier: 10.3390/cancers12040808

ISSN: 2072-6694